References
- Biondi, A., Cimino, G., Pieters, R. and Pui, C.H. (2000) "Biological and therapeutic aspects of infant leukemia", Blood 96, 24–33.
- Pui, C.H. and Evans, W.E. (1998) "Acute lymphoblastic leukemia", N. Eng. J. Med. 339, 605–615.
- Virgilio, J.F., Moscinski,Ballester, 0.F., Corrado, C., Guida,C., Balducci, L. and Saba, H. (1993) "Acute lymphocytic leukemia (ALL) in elderly patients", Hematot Oncol. 11, 121–126.
- Selvin, S. and Merrill, D.W. (2002) "Adult leukemia: a spatial analysis", Epidemiology 13, 151–156.
- Levi, F., Lucchini, F., Negri, E., Barbui, T. and La Vecchia, C. (2000) "Trends in mortality from leukemia in subsequent age groups", Leukemia 14, 1980–1985.
- D'Costa, S. and Hurwitz, J.L. (2003) "Customized mitogen or antibody treatments enhance the sensitivity of lymphoid tumors to 5-fluorouracil in vitro and in vivo", Leuk. Lvinphoma 44, 841–847.
- O'Flynn, K., Krensky, A.M., Beverley, P.C., Burakoff, S.J. and Linch, D.C. (1985) "Phytohaemagglutinin activation of T cells through the sheep red blood cell receptor", Nature 313, 686–687.
- Minegishi, M., Minegishi, N., Yanagisawa, T., Tsuchiya, S., Tezuka, H., Kaji, M., Nakamura, M., Hayashi, Y. and Konno, T. (1995) "A human CD4- CD8- 'F-cell receptor alpha beta + T leukemic cell line undergoing phytohemagglutinin-induced apoptosis", Leuk. Res. 19, 433–442.
- Bonay, M., Bouchonnet, F., Lecossier, D., Boumsell, L., Soler, P., Grodet, A., Robertson, M.J. and Hance, A.J. (1997) "Activation of T-cells through an antigen-independent alternative pathway induces precocious sensitivity to Fas-induced apoptosis", Immunol. Lett. 59, 107–113.
- Wesselborg, S., Janssen, a and Kabelitz, D. (1993) "Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells", J. hnmunol. 150, 4338–4345.
- Arinbjarnarson, S. and Valdimarsson, H. (2002) "Generation of heterohybridomas secreting human immunoglobulins; pokeweed mitogen prestimulation is highly effective but phytohemagglutinin drives most B cells into apoptosis", J. Immunol. Methods 259, 139–148.
- Monleon, 1., Martinez-Lorenzo, M.J., Monteagudo, L., Lasierra, P., Taules, M., Iturralde, M., Pineiro, A., Larrad, L., Alava, M.A., Naval, J. and Mel, A. (2001) "Differential secretion of Fas ligand-or AP02 ligand/TNF-related apoptosis-inducing ligand-carrying tnicrovesicles during activation-induced death of human T cells", J. Immunol. 167, 6736–6744.
- Martinez-Lorenzo, M.J., Anel, A., Gatnen, S., Monlion, I„ Lasierra, P., Larrad, L., Pineiro, A., Alava, M.A. and Naval, J. (1999) "Activated human T cells release bioactive Fas ligand and AP02 ligand in microvesicles", J. Immunol. 163, 1274–1281.
- Zheng, L., Fisher, G., Miller, R.E., Peschon, J., Lynch, D.H. and Lenardo, M.J. (1995) "Induction of apoptosis in mature T cells by tumour necrosis factor", Nature 377, 348–351.
- Houghton, J.A. and Houghton, P.J. (1980) "On the mechanism of cytotoxicity of fluorinated pyrimidines in four human colon adenocarcinoma xenografts maintained in immune- deprived mice", Cancer 45(5), 1159–1167.
- Kappler, J.W., Skidmore, B., White, J. and Marrack, P. (1981) "Antigen-inducible, H-2-restricted interleuldn-2-producing T cell hybridomas; Lack of independent antigen and H-2 recognition", J. Exp. Med. 153, 1198–1214.
- Germain, R.N. (1997) 'T-cell signaling: the importance of intracellular signal molecules", Curr. Biol. 7, R640–R644.
- Myung, P.S., Boerthe, NJ. and Koretzky, G.A. (2000) "Adapter proteins in lymphocyte antigen-receptor signaling", Curt Opin. Immunol. 12, 256–266.
- Fonseca, A.M., Porto, G., Uchida, K. and Arosa, F.A. (2001) "Red blood cells inhibit activation-induced cell death and oxidative stress in human peripheral blood T lymphocytes", Blood 97, 3152–3160.
- Paulova, M., Ticha, M., Entlicher, G., Kostir, J. and Kocourek, J. (1970) "Relationship between red blood cell agglutination and polysaccharide precipitation by phytohemagglutinin of Pisum Sativum L.", FEBS Lett. 9, 345–347.
- Pryme, I.E. Bardocz, S., Pusztai, A. and Ewen, S.W.B. (1999) "The growth of an established murine non-Hodgkin lymphoma tumour is limited by switching to a phytohaemagglutinin-containing diet", Cancer Lett. 146, 87–91.
- Old, L.J. (1988) "Tumor necrosis factor", Sci. Am., 59–75.
- Rencher, S.D., Slobod, K.S., Smith, ES. and Hurwitz, J.L. (1994) "Activity of transplanted CD8+ versus CD4÷ cytotoxic T-cells against Epstein-Barr virus immortalized B-cell tumors in SCID mice", Transplantation 58, 629–633.
- Slobod, K.S., Benaim, E., Woodruff, L., Nooner, S., Houston, J., Holladay, M., Lockey, T.D. and Hurwitz, J.L. (2001) "T cell immunotherapeutic populations control viral infections in bone marrow transplant recipients", Immunol. Res. 24, 289–301.
- Okuda, M., Sakaguchi, K., Tomiyama, S. and Takahashi, M. (1980) "Use of phytohemagglutinin in the treatment of maxillary cancer", Arch. Otorhinolcnyngol. 228, 127–134.
- Kotzin, B.L., Leung, D.Y., Kappler, J. and Marrack, P. (1993) "Superantigens and their potential role in human disease", Adv. Immunol. 54, 99–166.